Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

February 1, 2026

Conditions
IBDVenous ThromboembolismCrohn DiseaseUlcerative ColitisPulmonary EmbolismColorectal Disorders
Interventions
DRUG

Apixaban 2.5 milligram

2.5 milligram daily dosing of Apixaban beginning on the first day of hospital discharge for a total of 30 days

DRUG

Placebo Oral Tablet

placebo oral tablet that resembles the experimental drug. To be taken with the same frequency and duration

Trial Locations (2)

L8N 4A6

RECRUITING

St. Joseph's Healthcare, Hamilton

L8V 1C3

RECRUITING

Juravinski Hospital, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER